Retinal Ganglion Cell Death as a Late Remodeling Effect of Photoreceptor Degeneration.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Sep 2019
Historique:
received: 25 07 2019
revised: 09 09 2019
accepted: 17 09 2019
entrez: 25 9 2019
pubmed: 25 9 2019
medline: 6 2 2020
Statut: epublish

Résumé

Inherited or acquired photoreceptor degenerations, one of the leading causes of irreversible blindness in the world, are a group of retinal disorders that initially affect rods and cones, situated in the outer retina. For many years it was assumed that these diseases did not spread to the inner retina. However, it is now known that photoreceptor loss leads to an unavoidable chain of events that cause neurovascular changes in the retina including migration of retinal pigment epithelium cells, formation of "subretinal vascular complexes", vessel displacement, retinal ganglion cell (RGC) axonal strangulation by retinal vessels, axonal transport alteration and, ultimately, RGC death. These events are common to all photoreceptor degenerations regardless of the initial trigger and thus threaten the outcome of photoreceptor substitution as a therapeutic approach, because with a degenerating inner retina, the photoreceptor signal will not reach the brain. In conclusion, therapies should be applied early in the course of photoreceptor degeneration, before the remodeling process reaches the inner retina.

Identifiants

pubmed: 31546829
pii: ijms20184649
doi: 10.3390/ijms20184649
pmc: PMC6770703
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fundación Séneca
ID : 19881/GERM/15
Organisme : Ministerio de Economía y Competitividad
ID : SAF2015-67643-P
Organisme : Instituto de Salud Carlos III
ID : PI16/00380
Organisme : Instituto de Salud Carlos III
ID : RD16/0008/0026

Références

Prog Retin Eye Res. 1998 Apr;17(2):175-205
pubmed: 9695792
Biochem Biophys Res Commun. 2018 Jun 18;501(1):239-245
pubmed: 29723528
Invest Ophthalmol Vis Sci. 2016 Apr 1;57(5):ORSFg1-7
pubmed: 27116664
Int J Ophthalmol. 2018 May 18;11(5):756-765
pubmed: 29862172
Acta Neuropathol. 2009 Jul;118(1):103-13
pubmed: 19319544
Cell Death Dis. 2018 Mar 2;9(3):350
pubmed: 29500424
Front Cell Neurosci. 2016 Apr 28;10:103
pubmed: 27199657
PLoS One. 2012;7(10):e42017
pubmed: 23115615
Front Neuroanat. 2018 Jun 29;12:55
pubmed: 30008665
Exp Eye Res. 2008 Dec;87(6):561-70
pubmed: 18848932
Invest Ophthalmol Vis Sci. 2000 Feb;41(2):537-45
pubmed: 10670486
Glia. 2011 Jul;59(7):1107-17
pubmed: 21547953
Mol Vis. 2008 Apr 25;14:782-806
pubmed: 18483561
Invest Ophthalmol Vis Sci. 2011 Jun 28;52(7):4610-6
pubmed: 21296811
Front Neuroanat. 2014 Oct 06;8:99
pubmed: 25339868
Graefes Arch Clin Exp Ophthalmol. 2008 Nov;246(11):1553-8
pubmed: 18682972
Arch Ophthalmol. 1992 Nov;110(11):1634-9
pubmed: 1444925
J Anat. 2017 Oct;231(4):471-483
pubmed: 28695619
Br J Ophthalmol. 2014 Mar;98(3):396-401
pubmed: 24326325
EMBO Mol Med. 2015 Jul 02;7(9):1179-97
pubmed: 26139610
Front Cell Neurosci. 2015 Dec 23;9:494
pubmed: 26778960
Vision Res. 2009 Jan;49(1):115-26
pubmed: 18952118
Prog Retin Eye Res. 2015 May;46:31-66
pubmed: 25660226
Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1396-1409
pubmed: 29625463
Exp Eye Res. 2016 Sep;150:106-21
pubmed: 26521764
Prog Retin Eye Res. 2018 Jan;62:24-37
pubmed: 28962928
Eye (Lond). 2019 Mar;33(3):428-434
pubmed: 30310161
Neuroscience. 2016 Aug 4;329:1-11
pubmed: 27132232
J Neurosci. 2008 Jan 9;28(2):548-61
pubmed: 18184797
Vision Res. 2009 Nov;49(23):2808-25
pubmed: 19715716
Prog Retin Eye Res. 2003 Sep;22(5):607-55
pubmed: 12892644
J Comp Neurol. 2006 Sep 10;498(2):163-79
pubmed: 16856141
Neural Regen Res. 2019 Jul;14(7):1186-1190
pubmed: 30804243
Prog Retin Eye Res. 2017 May;58:1-27
pubmed: 28111323
Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2318-28
pubmed: 10892879
Exp Eye Res. 2016 Oct;151:96-106
pubmed: 27523467
Prog Retin Eye Res. 2014 Nov;43:17-75
pubmed: 25038518
Neural Regen Res. 2015 Aug;10(8):1228-30
pubmed: 26487846
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3533-44
pubmed: 27379578
Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):3221-3235
pubmed: 31335948
PLoS One. 2014 Oct 24;9(10):e110612
pubmed: 25343338
Arch Ophthalmol. 1997 Apr;115(4):511-5
pubmed: 9109761
PLoS One. 2013 Sep 11;8(9):e71570
pubmed: 24039718
Ophthalmology. 2019 Jan;126(1):55-63
pubmed: 30077616
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4487-98
pubmed: 26193926
Subcell Biochem. 2019;91:477-499
pubmed: 30888663
Prog Brain Res. 2015;220:1-35
pubmed: 26497783
Invest Ophthalmol Vis Sci. 2009 Aug;50(8):3860-8
pubmed: 19264888
Exp Eye Res. 2010 Dec;91(6):800-10
pubmed: 20955700
Lab Anim (NY). 2018 Mar;47(3):71-75
pubmed: 29483694
Neural Regen Res. 2016 Aug;11(8):1243-4
pubmed: 27651769
Mol Vis. 2012;18:675-93
pubmed: 22509098
BMC Neurosci. 2019 Sep 3;20(1):46
pubmed: 31481030
Exp Eye Res. 2018 Feb;167:56-90
pubmed: 29122605
Exp Eye Res. 2017 Aug;161:10-16
pubmed: 28552384
Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3364-71
pubmed: 17591910
Transl Pediatr. 2015 Apr;4(2):139-63
pubmed: 26835369
Neuron. 2017 Sep 27;96(1):17-42
pubmed: 28957666
Acta Ophthalmol. 2016 Dec;94(8):748-754
pubmed: 27350263
Eur J Neurosci. 2002 May;15(9):1433-43
pubmed: 12028353
Mol Vis. 2011;17:1716-33
pubmed: 21738401
Invest Ophthalmol Vis Sci. 2008 Aug;49(8):3525-8
pubmed: 18421083
J Comp Neurol. 2014 Apr 1;522(5):1155-70
pubmed: 24519018
Brain Res. 2010 Mar 19;1321:60-6
pubmed: 20114037
Neural Regen Res. 2018 Nov;13(11):1885-1886
pubmed: 30233058
Stem Cells. 2017 Apr;35(4):932-939
pubmed: 27977075
Transl Vis Sci Technol. 2019 May 30;8(3):31
pubmed: 31171998
PLoS One. 2014 Dec 02;9(12):e113798
pubmed: 25464513
Exp Eye Res. 2009 Mar;88(3):589-99
pubmed: 19087876
J Comp Neurol. 2003 Sep 8;464(1):1-16
pubmed: 12866125
Int J Biochem Cell Biol. 2009 Jul;41(7):1581-91
pubmed: 19401152
Vision Res. 2002 Feb;42(4):393-9
pubmed: 11853755
Front Neuroanat. 2017 Mar 06;11:14
pubmed: 28321183
Curr Eye Res. 2003 Sep;27(3):183-96
pubmed: 14562184
J Neurosci. 2019 Aug 21;39(34):6798-6810
pubmed: 31285302
Mol Vis. 2012;18:1197-214
pubmed: 22665967
Sci Transl Med. 2016 Dec 7;8(368):368rv6
pubmed: 27928030
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4592-604
pubmed: 26200499
Clin Exp Optom. 2005 Sep;88(5):282-91
pubmed: 16255687
Exp Eye Res. 2003 Apr;76(4):463-71
pubmed: 12634111
PLoS One. 2013 Jun 28;8(6):e68084
pubmed: 23840814
Prog Retin Eye Res. 2016 Mar;51:1-40
pubmed: 26113209
J Comp Neurol. 1998 Mar 2;392(1):58-77
pubmed: 9482233
Exp Eye Res. 2016 Sep;150:62-70
pubmed: 27142256
Prog Retin Eye Res. 2019 Mar;69:1-37
pubmed: 30445193
J Comp Neurol. 2012 May 1;520(7):1406-23
pubmed: 22102216
Prog Retin Eye Res. 2009 Nov;28(6):423-51
pubmed: 19660572
Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4392-4403
pubmed: 30193320
Ophthalmology. 1982 Dec;89(12):1425-32
pubmed: 7162785
Bull World Health Organ. 2004 Nov;82(11):844-51
pubmed: 15640920
Ther Adv Ophthalmol. 2019 Jan 17;11:2515841418817501
pubmed: 30729233
Exp Eye Res. 2010 Jan;90(1):168-83
pubmed: 19835874
Lancet. 2006 Nov 18;368(9549):1795-809
pubmed: 17113430
Annu Rev Vis Sci. 2018 Sep 15;4:45-77
pubmed: 29852094
Prog Retin Eye Res. 2019 Jul 26;:null
pubmed: 31356876
Neuroreport. 1996 Aug 12;7(12):1995-9
pubmed: 8905711
J Neurochem. 2018 Mar;144(5):617-633
pubmed: 29210074
J Neurosci. 2008 Dec 24;28(52):14282-92
pubmed: 19109509
Prog Retin Eye Res. 2012 Jan;31(1):1-27
pubmed: 21946033
Mol Vis. 2008 Jun 03;14:1050-63
pubmed: 18552980
Lancet Glob Health. 2014 Feb;2(2):e106-16
pubmed: 25104651
Invest Ophthalmol Vis Sci. 2009 Jun;50(6):3017-23
pubmed: 19182251
Sci Rep. 2018 Jan 31;8(1):1968
pubmed: 29386551
Exp Eye Res. 2016 Sep;150:122-34
pubmed: 26521765
Exp Eye Res. 2016 Sep;150:149-65
pubmed: 27020758
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):3171-83
pubmed: 20071667
Curr Opin Ophthalmol. 2019 May;30(3):199-205
pubmed: 30844942
Exp Eye Res. 2019 Nov;188:107781
pubmed: 31473259
Invest Ophthalmol Vis Sci. 2013 Aug 28;54(8):5888-900
pubmed: 23908186
Neuroophthalmology. 2016 Oct 6;40(6):286-291
pubmed: 27928420
Exp Eye Res. 2018 Sep;174:93-97
pubmed: 29856984
Front Neurosci. 2017 Apr 26;11:235
pubmed: 28491019
Nature. 2017 Feb 16;542(7641):367-371
pubmed: 28178240
Invest Ophthalmol Vis Sci. 2009 Jan;50(1):424-31
pubmed: 18775855
Prog Retin Eye Res. 2003 Jan;22(1):95-111
pubmed: 12597925
Invest Ophthalmol. 1966 Oct;5(5):450-73
pubmed: 5929286
Prog Retin Eye Res. 2018 Mar;63:107-131
pubmed: 29097191
Front Cell Neurosci. 2016 Feb 17;10:38
pubmed: 26924962
Ophthalmic Res. 2016;56(3):111-22
pubmed: 27352292
PLoS One. 2017 May 9;12(5):e0177224
pubmed: 28486508
Biochimie. 2016 Jun;125:171-8
pubmed: 27059514
Retina. 2018 Nov;38(11):2159-2167
pubmed: 29117065

Auteurs

Diego García-Ayuso (D)

Departamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, and Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Virgen de la Arrixaca), 30120 Murcia, Spain. diegogarcia@um.es.

Johnny Di Pierdomenico (J)

Departamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, and Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Virgen de la Arrixaca), 30120 Murcia, Spain. johnnydp@um.es.

Manuel Vidal-Sanz (M)

Departamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, and Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Virgen de la Arrixaca), 30120 Murcia, Spain. manuel.vidal@um.es.

María P Villegas-Pérez (MP)

Departamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, and Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Virgen de la Arrixaca), 30120 Murcia, Spain. mpville@um.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH